127 related articles for article (PubMed ID: 27922892)
1. Galectin-3 Expression in Benign and Malignant Skin Diseases With Epidermal Hyperplasia.
Jiang ZX; Tan GZ; Shi ZR; Zhang YP; Han YF; Wang L
Am J Dermatopathol; 2017 Oct; 39(10):738-741. PubMed ID: 27922892
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical comparison of beta-catenin expression by human normal epidermis and epidermal tumors.
Fukumaru K; Yoshii N; Kanzaki T; Kanekura T
J Dermatol; 2007 Nov; 34(11):746-53. PubMed ID: 17973813
[TBL] [Abstract][Full Text] [Related]
3. Association of ras p21 with differentiation of epidermal keratinocytes in proliferating skin diseases.
Kikuchi A; Amagai M; Nishikawa T
J Dermatol Sci; 1992 Sep; 4(2):83-6. PubMed ID: 1419983
[TBL] [Abstract][Full Text] [Related]
4. p53 expression in pseudoepitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma of skin.
Lee YS; Teh M
Cancer; 1994 May; 73(9):2317-23. PubMed ID: 8168036
[TBL] [Abstract][Full Text] [Related]
5. The insulin-like growth factor 1 receptor is expressed by epithelial cells with proliferative potential in human epidermis and skin appendages: correlation of increased expression with epidermal hyperplasia.
Hodak E; Gottlieb AB; Anzilotti M; Krueger JG
J Invest Dermatol; 1996 Mar; 106(3):564-70. PubMed ID: 8648195
[TBL] [Abstract][Full Text] [Related]
6. Proliferation and differentiation of the keratinocytes in hyperplastic epidermis overlying dermatofibroma: immunohistochemical characterization.
Han KH; Huh CH; Cho KH
Am J Dermatopathol; 2001 Apr; 23(2):90-8. PubMed ID: 11285402
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin.
Krunic AL; Garrod DR; Madani S; Buchanan MD; Clark RE
Br J Cancer; 1998 Apr; 77(8):1275-9. PubMed ID: 9579833
[TBL] [Abstract][Full Text] [Related]
8. Cytologic features of hyperplastic epidermis.
Eng AM; Worobec S
J Cutan Pathol; 1977 Oct; 4(5):258-65. PubMed ID: 604366
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical localization of basic fibroblast growth factor in skin diseases.
Yaguchi H; Tsuboi R; Ueki R; Ogawa H
Acta Derm Venereol; 1993 Apr; 73(2):81-3. PubMed ID: 8103271
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptors in idiopathic and virally induced skin diseases.
Nanney LB; Ellis DL; Levine J; King LE
Am J Pathol; 1992 Apr; 140(4):915-25. PubMed ID: 1532884
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical galectin-3 expression in non-melanoma skin cancers.
Kapucuoglu N; Basak PY; Bircan S; Sert S; Akkaya VB
Pathol Res Pract; 2009; 205(2):97-103. PubMed ID: 18951731
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of galectin-3 in papillary projections of malignant and non-malignant hyperplastic thyroid lesions.
Cvejić D; Savin S; Petrović I; Paunović I; Tatić S; Havelka M
Acta Chir Iugosl; 2003; 50(3):67-70. PubMed ID: 15179758
[TBL] [Abstract][Full Text] [Related]
13. Expression of TWEAK in normal human skin, dermatitis and epidermal neoplasms: association with proliferation and differentiation of keratinocytes.
Peternel S; Manestar-Blažić T; Brajac I; Prpić-Massari L; Kaštelan M
J Cutan Pathol; 2011 Oct; 38(10):780-9. PubMed ID: 21797919
[TBL] [Abstract][Full Text] [Related]
14. Regulatory mechanisms of galectin-9 and eotaxin-3 synthesis in epidermal keratinocytes: possible involvement of galectin-9 in dermal eosinophilia of Th1-polarized skin inflammation.
Igawa K; Satoh T; Hirashima M; Yokozeki H
Allergy; 2006 Dec; 61(12):1385-91. PubMed ID: 17073866
[TBL] [Abstract][Full Text] [Related]
15. Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement.
Lu S; Tiekso J; Hietanen S; Syrjänen K; Havu VK; Syrjänen S
Acta Derm Venereol; 1999 Jul; 79(4):268-73. PubMed ID: 10429981
[TBL] [Abstract][Full Text] [Related]
16. Stromal CD10 expression, as well as increased dermal macrophages and decreased Langerhans cells, are associated with malignant transformation of keratinocytes.
Takahara M; Chen S; Kido M; Takeuchi S; Uchi H; Tu Y; Moroi Y; Furue M
J Cutan Pathol; 2009 Jun; 36(6):668-74. PubMed ID: 19515046
[TBL] [Abstract][Full Text] [Related]
17. Localization of MGSA/GRO protein in cutaneous lesions.
Tettelbach W; Nanney L; Ellis D; King L; Richmond A
J Cutan Pathol; 1993 Jun; 20(3):259-66. PubMed ID: 8366215
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic characterization of human keratinocytes in coculture reveals differential effects of fibroblasts from benign fibrous histiocytoma (dermatofibroma) as compared to cells from its malignant form and to normal fibroblasts.
Kideryová L; Lacina L; Dvoránková B; Stork J; Cada Z; Szabo P; André S; Kaltner H; Gabius HJ; Smetana K
J Dermatol Sci; 2009 Jul; 55(1):18-26. PubMed ID: 19414239
[TBL] [Abstract][Full Text] [Related]
19. Expression of cytokeratin 19, HBME-1 and galectin-3 in neoplastic and nonneoplastic thyroid lesions.
Mataraci EA; Ozgüven BY; Kabukçuoglu F
Pol J Pathol; 2012 Mar; 63(1):58-64. PubMed ID: 22535608
[TBL] [Abstract][Full Text] [Related]
20. Distribution of metallothionein in normal and pathological human skin.
van den Oord JJ; De Ley M
Arch Dermatol Res; 1994; 286(1):62-8. PubMed ID: 8141614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
